SPUR Trademark

Trademark Overview


On Monday, September 23, 2024, a trademark application was filed for SPUR with the United States Patent and Trademark Office. The USPTO has given the SPUR trademark a serial number of 79407514. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 4, 2025. This trademark is owned by Freeline Therapeutics Limited. The SPUR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical research and development services; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of Gaucher disease, and Parkinson's disease; all of the aforementioned being related to human health.

Pharmaceutical and medical preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for gene therapy for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for Gaucher disease and Parkinson's disease; Pharmaceutical and medical preparations for gene therapy for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned for human use.
spur

General Information


Serial Number79407514
Word MarkSPUR
Filing DateMonday, September 23, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 25, 2025

Trademark Statements


Goods and ServicesPharmaceutical research and development services; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of Gaucher disease, and Parkinson's disease; all of the aforementioned being related to human health.
Goods and ServicesPharmaceutical and medical preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for gene therapy for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for Gaucher disease and Parkinson's disease; Pharmaceutical and medical preparations for gene therapy for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpur Therapeutics Limited
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressStevenage, Hertfordshire SG1 2BP
GB

Party NameFreeline Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, October 24, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 24, 2024APPLICATION FILING RECEIPT MAILED
Friday, December 20, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, March 18, 2025ASSIGNED TO EXAMINER
Thursday, March 20, 2025NON-FINAL ACTION WRITTEN
Friday, March 21, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 6, 2025REFUSAL PROCESSED BY MPU
Tuesday, May 6, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, May 24, 2025REFUSAL PROCESSED BY IB
Tuesday, October 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 26, 2025APPROVED FOR PUB - PRINCIPAL REGISTER